Lotte is looking toward more industry innovation with the proactive adoption of AI across the group’s array of businesses. The intent is to go beyond enhancing efficiency to strengthen corporate competitive advantage. Moreover, Lotte is preparing...
Lotte Biologics began construction on its 360,000-liter production site in Songdo, Incheon.
Lotte Corporation will funnel 120 billion won ($86.4 million) into Lotte Biologics for the biopharmaceutical contract manufacturer’s upcoming production plant in Incheon.
Lotte Biologics and Merck, a German chemical and technology giant, signed an agreement for a strategic collaboration in biomanufacturing.
With the global life science industry’s eyes set on San Francisco, Korea’s emerging or rising biopharma companies gathered in the Bay area to join the annual J.P. Morgan Healthcare Conference.
Samsung Biologics has filed another police report against departing employees set to join Lotte Biologics, alleging trade secret infringement.
BARCELONA, Spain — Lotte Biologics, a biopharmaceutical contract manufacturer, aims to go public by around 2027 to 2028, according to its CEO.
Samsung Biologics is eyeing new opportunities in Barcelona as it showcases its fifth plant at the CPHI Worldwide 2023 event, the world's largest pharmaceutical trade show.
CPHI Worldwide, the largest pharmaceutical trade show, started in Barcelona with major Korean biopharma players in attendance. Over 2,500 companies from 170 countries are exhibiting.
Lotte Biologics signed an agreement with Roche Diagnostics to further improve its contract development and manufacturing organization capabilities, the Korean company said Wednesday.
Korea JoongAng Daily Sitemap
